Front-Runners Emerge in the Race for a Covid-19 Vaccine

It’s been four months since researchers in China sequenced the novel coronavirus now known as SARS-CoV-2. In those four months, at least 3.8 million people around the world have been diagnosed with Covid-19, the deadly respiratory disease it causes. As of Friday morning, more than 267,000 people have died. Doctors have been trying lots of existing drugs—from malaria medications to anti-influenza pills to Ebola treatments—in an effort to save patients from the ravages of the disease, which can damage the heart, kidneys, brain, and lungs. But so far, no blockbusters have emerged. Researchers are still testing hundreds of potential candidates in search of a cure. Everything You Need to Know About the Coronavirus Here’s all the WIRED coverage in one place, from how to keep your children entertained to how this outbreak is affecting the economy. By Eve Sneider A vaccine, which would teach people’s immune systems to recognize and fend off the virus before an infection can take hold, would be even better. An inoculated public could get back to work, stop sheltering in place, resume normal life. Developing a safe, effective vaccine against a new pathogen typically takes years, if not decades. That’s because, unlike with experimental treatments,… Read full this story

Front-Runners Emerge in the Race for a Covid-19 Vaccine have 263 words, post on www.wired.com at May 8, 2020. This is cached page on Drudgereport. If you want remove this page, please contact us.